Lucy Tobin: With endless remedies to choose from, what went wrong?
When AstraZeneca was wheeled into A&E a few years ago, bleeding revenues everywhere and its growth stunted by a lack of vitamins R&D, the professionals knew the prognosis was grim. They tried a bit of this and that: lowering medical costs by firing thousands of carers; buying some new body parts like the $15.6bn acquisition of MedImmune in 2007.
But nothing worked. And then, to stretch the analogy a little, just when they thought things couldn't get worse, the patient's head fell off. Or was cut off. No one will say.
Almost all of Astra's blockbuster medicines are now facing generic competition on the pharmacy shelves, or soon will. Three major pipeline hopes have failed in as many months. And there's only so long a company can hypnotise investors with cash hand-outs.
In that context, it's little wonder a German investor at the drug maker's AGM yesterday said he was "astounded" at Mr Brennan's "leav[ing] the ship on high seas". AstraZeneca's headhunters are going to have one hell of a job finding someone to take over.
In some ways, it's not such a different situation from when Mr Brennan replaced Sir Tom McKillop at the top of AstraZeneca in 2006. At the time, he joked with a colleague who had come to congratulate him: "Great job, shit timing." Could Mr Brennan have done more in his six years in charge? If instead of chucking almost $16bn at MedImmune he had made a play for Shire, the Dublin-headquartered drug maker that has made serious progress on its pipeline, Astra might not be in the state it's in today. Worse, though, was Mr Brennan's decision to cut back on research and development at the time when Astra needed it most.
It was that which put the drug maker into intensive care. Only time will tell if it pulls through.
- 1 Home Office says Nigerian asylum-seeker can’t be a lesbian as she’s got children
- 2 What happens to your body when you give up sugar?
- 3 Drugs Live cannabis trial: Hash is less harmful than any other drug, expert claims
- 4 Turkish Airlines flight TK 726 crash-lands on Nepal runway amid dense fog
- 5 Apple and Google users being spied on for a decade because of 'Freak' security flaw
The City of the Monkey God: Archaeologists claim to have found city lost for 1,000 years in remote Honduran jungle
Turkish Airlines flight TK 726 crash-lands on Nepal runway amid dense fog
Japanese island overrun with cats after population explodes
Bubonic plague-carrying fleas found on New York City rats
London property boom built on dirty money
'Jihadi John': CAGE representative storms off Sky News accusing Kay Burley of Islamophobia
Nearly 100,000 of Britain's poorest children go hungry after parents' benefits are cut
Durham Free School: 'Creationism taught at' free school facing closure
Ukip would cut billions from Scottish budget to fund English tax cuts
End of the licence fee: BBC to back radical overhaul of how it is funded
Ukraine crisis: Top Chinese diplomat backs Putin and says West should 'abandon zero-sum mentality'
iJobs Money & Business
£25000 - £30000 per annum + benefits: Ashdown Group: A global leader operating...
Voluntary post, reasonable expenses reimbursed: Reach Volunteering: Would you ...
£36,000 - £40,000: Christine McCleave: Are you looking for a new opportunity a...
£15000 - £18000 per annum: Recruitment Genius: This is a great opportunity for...